Assessment of incidence of rebound pain in below knee surgery patients

Assessment of incidence of rebound pain after use of dexamethasone with ropivacaine for sciatic nerve block in below knee surgeries - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/09/057930

Enrollment

Registered

2023-09-21

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Sciatic nerve block: 20ml of 0.2% Ropivacaine with 4mg of Dexamethasone Control Intervention1: Sciatic nerve block: 20ml of 0.2% Ropivacaine with 1ml of distilled water

Eligibility

Inclusion criteria

Inclusion criteria: Age between 18 to 60 years ASA Grade 1 AND 2 Patients undergoing elective below knee surgeries under regional anaesthesia

Exclusion criteria

Exclusion criteria: BMI > 35kg/m2 Patients with known allergy to study medications Patients with coagulation diosorders, neurological disorders, hepatic or renal insufficiency

Design outcomes

Primary

Measure	Time frame
To determine the role of Dexamethasone in delaying the incidence of rebound pain after sciatic nerve block using 0.2% Ropivacaine for below knee surgeriesTimepoint: 24 hours	—

Secondary

Measure	Time frame
To evaluatethe number of rescue analgesiablouses required within a period of 24 hours To assess the incidence of chronic pain after a duration of 3 months by NRS scaleTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDiksha

Kalinga Institute Of Medical Sciences

trajmohan.rao@kims.ac.in9701185818

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026